MRVL Pet Pharmaceuticals Corp. Announces Changes to Management and Board of Directors
Company or
MRVL ), a life sciences and technology company focused on the animal health sector, is pleased to announce the appointments of Dr. Joel Beth Navratik, current Chief Executive Officer (
CEO ) of the Company, as President and a Director of the Company, and Ivan Hsu as Chief Operating Officer (
COO ) and Chief Financial Officer (
CFO ) of the Company, effective May 31, 2021, following the resignations of Derrick Gaon as Director and President and Ronald Ozols as CFO, Vice President, and Corporate Secretary.
The Company is also pleased to announce the appointments of Vyvyan Campbell and Patricia Trompeter to the Company s Board of Directors (the
Aventura
Florida
United-states
New-york
Cornell-university
Texas
University-of-florida
Dallas
Anderson-school
Toronto
Ontario
Canada